CN112543762A - 一种羊毛甾醇前药化合物的晶型及其应用 - Google Patents

一种羊毛甾醇前药化合物的晶型及其应用 Download PDF

Info

Publication number
CN112543762A
CN112543762A CN201980049648.9A CN201980049648A CN112543762A CN 112543762 A CN112543762 A CN 112543762A CN 201980049648 A CN201980049648 A CN 201980049648A CN 112543762 A CN112543762 A CN 112543762A
Authority
CN
China
Prior art keywords
lanosterol
degrees
eye
lens
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201980049648.9A
Other languages
English (en)
Other versions
CN112543762B (zh
Inventor
刘奕志
王延东
李小林
罗志
贺海鹰
黎健
陈曙辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Runer Eye Medicine Guangzhou Co ltd
Guangzhou Ocusun Ophthalmic Biotechnology Co Ltd
Original Assignee
Guangzhou Ocusun Ophthalmic Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Ocusun Ophthalmic Biotechnology Co Ltd filed Critical Guangzhou Ocusun Ophthalmic Biotechnology Co Ltd
Publication of CN112543762A publication Critical patent/CN112543762A/zh
Application granted granted Critical
Publication of CN112543762B publication Critical patent/CN112543762B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

涉及式(Ⅰ)化合物的晶型，以及该晶型在制备治疗眼科疾病药物中的应用。

Description

PCT国内申请，说明书已公开。

Claims (9)

  1. PCT国内申请，权利要求书已公开。
CN201980049648.9A 2018-07-25 2019-07-25 一种羊毛甾醇前药化合物的晶型及其应用 Active CN112543762B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018108264256 2018-07-25
CN201810826425 2018-07-25
PCT/CN2019/097773 WO2020020306A1 (zh) 2018-07-25 2019-07-25 一种羊毛甾醇前药化合物的晶型及其应用

Publications (2)

Publication Number Publication Date
CN112543762A true CN112543762A (zh) 2021-03-23
CN112543762B CN112543762B (zh) 2022-11-08

Family

ID=69180373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980049648.9A Active CN112543762B (zh) 2018-07-25 2019-07-25 一种羊毛甾醇前药化合物的晶型及其应用

Country Status (16)

Country Link
US (1) US11149055B2 (zh)
EP (1) EP3828193A4 (zh)
JP (1) JP7046266B2 (zh)
KR (1) KR20210038596A (zh)
CN (1) CN112543762B (zh)
AU (1) AU2019308940B2 (zh)
BR (1) BR112021001172A2 (zh)
CA (1) CA3107361C (zh)
CO (1) CO2021000932A2 (zh)
MA (1) MA53397A (zh)
MX (1) MX2021000900A (zh)
PH (1) PH12021550182A1 (zh)
RU (1) RU2766088C1 (zh)
SG (1) SG11202100665WA (zh)
WO (1) WO2020020306A1 (zh)
ZA (1) ZA202100923B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023030430A1 (zh) * 2021-09-03 2023-03-09 成都瑞沐生物医药科技有限公司 一种滴眼给药预防和/或治疗白内障的眼用制剂

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220133744A1 (en) * 2019-03-04 2022-05-05 Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. Composition of lanosterol prodrug compound, preparation method therefor and use thereof
CN117957002A (zh) * 2021-08-18 2024-04-30 广州润尔眼科生物科技有限公司 一种药物组合物及其制备方法和应用
AU2022328942A1 (en) * 2021-08-18 2024-03-07 Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. Application of steroid compound in preparation of drug for preventing and/or treating eye floaters
WO2023143452A1 (zh) * 2022-01-28 2023-08-03 广州润尔眼科生物科技有限公司 甾体化合物在预防和/或治疗白内障中的应用
WO2023147640A1 (en) * 2022-02-07 2023-08-10 GERVÁSIO ALVES DA SILVA, Társis Preparation of novel triterpene alcohol derivatives with enhanced bioavailability for cancer, inflammation and pain treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016029197A1 (en) * 2014-08-22 2016-02-25 Kang Zhang Compositions and methods to treat and/or prevent vision disorders of the lens of the eye
WO2018137683A1 (zh) * 2017-01-25 2018-08-02 中山大学中山眼科中心 羊毛甾醇前药化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757062A (en) 1985-11-01 1988-07-12 E. I. Du Pont De Nemours And Company Substituted benzoate ester prodrugs of estrogens
DE3540702A1 (de) 1985-11-16 1987-05-21 Bayer Ag 1h-pyrido-(2,3-b) (1,4)-thiazine
RU2283318C1 (ru) * 2005-02-24 2006-09-10 Любовь Степановна Ермолова Способ производства стеринов: ланостерола и холестерола из шерстного жира
CN107206009B (zh) * 2014-08-22 2020-03-27 广州康睿生物医药科技股份有限公司 用于治疗视觉障碍的组合物和方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016029197A1 (en) * 2014-08-22 2016-02-25 Kang Zhang Compositions and methods to treat and/or prevent vision disorders of the lens of the eye
US20170239273A1 (en) * 2014-08-22 2017-08-24 Kang Zhang Compositions and methods to treat and/or prevent vision disorders of the lens of the eye
WO2018137683A1 (zh) * 2017-01-25 2018-08-02 中山大学中山眼科中心 羊毛甾醇前药化合物及其制备方法和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023030430A1 (zh) * 2021-09-03 2023-03-09 成都瑞沐生物医药科技有限公司 一种滴眼给药预防和/或治疗白内障的眼用制剂

Also Published As

Publication number Publication date
SG11202100665WA (en) 2021-02-25
AU2019308940A1 (en) 2021-03-11
JP2021524499A (ja) 2021-09-13
ZA202100923B (en) 2021-10-27
EP3828193A1 (en) 2021-06-02
CA3107361C (en) 2022-03-22
MA53397A (fr) 2021-06-02
US11149055B2 (en) 2021-10-19
US20210246158A1 (en) 2021-08-12
PH12021550182A1 (en) 2022-02-21
EP3828193A4 (en) 2022-06-29
JP7046266B2 (ja) 2022-04-01
AU2019308940B2 (en) 2024-02-08
WO2020020306A1 (zh) 2020-01-30
CO2021000932A2 (es) 2021-02-17
CA3107361A1 (en) 2020-01-30
MX2021000900A (es) 2021-06-15
RU2766088C1 (ru) 2022-02-07
BR112021001172A2 (pt) 2021-04-27
KR20210038596A (ko) 2021-04-07
CN112543762B (zh) 2022-11-08

Similar Documents

Publication Publication Date Title
CN112543762B (zh) 一种羊毛甾醇前药化合物的晶型及其应用
EP3271349B1 (en) Benzimidazole derivatives as bromodomain inhibitors
EA025407B1 (ru) Полиморфная форма i (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
WO2022121670A1 (zh) Tolebrutinib的晶型及其制备方法和用途
EP3858830B1 (en) Crystal form of morpholino quinazoline compound, preparation method therefor and use thereof
CN113336768B (zh) 一种多靶点酪氨酸激酶抑制剂
CN114591389A (zh) 一种甾体化合物及其制备方法与应用
CN113943266A (zh) 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
EP2607370A2 (en) Amorphous form of beta- L-2'-deoxythymidine
WO2009093208A2 (ru) ЗАМЕЩЕННЫЕ 2-AMИHO-3-CУЛЬФOHИЛ-ПИPAЗOЛO[1,5-a]ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2009093206A2 (ru) 3-CУЛЬФOHИЛ-ПИPAЗOЛO[1,5-a]ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
US20220185820A1 (en) Brd4 inhibitor compound in solid form and preparation method therefor and use thereof
US7550592B2 (en) Hydromorphone polymorphs
CN111518157A (zh) 一种雷公藤甲素衍生物及其制备方法和应用
CN112262138A (zh) 盐形式
JP2020522472A (ja) Ｐｋｃ阻害剤の固体状態形態
CN112105622B (zh) 丙戊酸磷脂衍生物的晶型及其制备方法
WO2022048675A1 (zh) Risdiplam晶型及其制备方法和用途
US20220340549A1 (en) Crystalline form of cxcr2 antagonist and application thereof
US20230312551A1 (en) Salt of 2-(substituted pyrimidinyl) thiazole carboxamide compound, and composition and use thereof
CN116082182A (zh) 秋水仙碱衍生物的制备方法及其用途
CN116253700A (zh) 一种大麻二酚衍生物及其制备方法和应用
CN115626917A (zh) 化合物的晶型及其组合物和用途
CN113861182A (zh) 嘧啶噻唑甲酰胺化合物的磷酸盐及其晶型
CN113861184A (zh) 2-(取代的嘧啶基)噻唑甲酰胺化合物的磷酸盐及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40043718

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: 511400 Room 402, No. 223, Huanshi Avenue West, Nansha District, Guangzhou, Guangdong

Patentee after: Guangzhou runer eye Biotechnology Co.,Ltd.

Address before: 510627 room 1108, No. 100, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province

Patentee before: Guangzhou runer eye Biotechnology Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240119

Address after: 511400 Room 402, No. 223, Huanshi Avenue West, Nansha District, Guangzhou, Guangdong

Patentee after: Guangzhou runer eye Biotechnology Co.,Ltd.

Patentee after: Runer Eye Medicine (Guangzhou) Co.,Ltd.

Address before: 511400 Room 402, No. 223, Huanshi Avenue West, Nansha District, Guangzhou, Guangdong

Patentee before: Guangzhou runer eye Biotechnology Co.,Ltd.